Hyperandrogenic anovulation (the polycystic ovary syndrome) - Back to the ovary?

Human Reproduction Update

Volumn 4, Issue 3, 1998, Pages 296-300

  Ben Shlomo, Izhar ^a,b,c,d   Homburg, Roy ^e   Shalev, Eliezer ^a,b,c,d  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e NONE

Author keywords

Androgens; Body mass; Insulin; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; CLOMIFENE CITRATE; FOLLITROPIN; INSULIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ANOVULATION; BODY MASS; DISEASE SEVERITY; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPERANDROGENISM; HYPOTHESIS; INSULIN RESISTANCE; LEAN BODY WEIGHT; LUTEINIZING HORMONE BLOOD LEVEL; OVARY FOLLICLE ATRESIA; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TESTOSTERONE BLOOD LEVEL;

ANOVULATION; FEMALE; HUMANS; HYPERANDROGENISM; INSULIN; OVARY; POLYCYSTIC OVARY SYNDROME;

EID: 0031692127     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/4.3.296     Document Type: Review

References (39)

1. Adams, J., Poison, D.W. and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J., 293, 355-359.
2. Adashi, E.Y. (1984) Clomiphene citrate: mechanism(s) and site(s) of action - a hypothesis revisited. Fertil. Steril., 42, 331-344.
3. Adashi, E.Y. (1995) With a little help from my friends - the evolving story of intraovarian regulation. Endocrinology, 136, 4161-4162.
4. Balen, A.H. and Jacobs, H.S. (1994) A prospective study comparing unilateral and bilateral laparoscopic ovarian diathermy in women with the polycystic ovary syndrome. Fertil. Steril., 62, 921-925.
5. Ben-Shlomo, I. and Zohar, S. (1989) Quadruplets following cessation of clomiphene citrate: a case of sustained effect. Acta Obstet. Gynecol. Scand., 68, 379-380.
6. Bilenka, B., Ben-Shlomo, I., Cozacov, C. et al. (1995) Fertility, miscarriage and pregnancy after vertical banded gastroplasty operation for morbid obesity. Acta Obstet. Gynecol. Scand., 74, 42-44.
7. Billig, H., Furuta, I. and Hsueh, A.J. (1993) Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology, 133, 2204-2212.
8. Billig, H., Chun, S.Y., Eisenhauer, K. and Hsueh, A.J. (1996) Gonadal cell apoptosis: hormone-regulated cell demise. Hum. Reprod. Update, 2, 103-117.
9. Brännstrom, M., Larson, L., Basta, B. and Hedin, L. (1989) Regulation of prostaglandin endoperoxide synthase by cyclic adenosine 3',5'-monophosphate in the in vitro-perfused rat ovary. Biol. Reprod., 41, 513-521.
10. Buyalos, R.P., Geffner, M.E., Bersch, N. et al. (1992) Insulin and insuin growth factor-I responsiveness in polycystic ovarian syndrome. Fertil. Steril., 57, 796-803.
11. Carey, A.H., Chan, K.L., Short, F. et al. (1993) Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin. Endocrinol., 38, 653-658.
12. Conway, G.S. and Jacobs, H.S. (1997) Leptin: a hormone of reproduction. Hum. Reprod., 12, 633-635.
13. Conway, G.S., Honour, J.W. and Jacobs, H.S. (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin. Endocrinol., 30, 459-470.
14. Dale, P.O., Tanbo, T., Vaaler, S. and Abyholm, T. (1992) Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil. Steril., 58, 487-491.
15. Donesky, B.W. and Adashi, E.Y. (1995) Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil. Steril., 63, 439-463.
16. Dunaif, A., Xia, J., Book, C.B., Schenker, E. et al. (1995) Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J. Clin. Invest., 96, 801-810
17. Eden, J.A. (1994) Hirsutism. In Studd, J. (ed.), Progress in Obstetrics and Gynecology. Churchill Livingstone, London, Vol. 9, pp. 319-334.
18. Franks, S., Gharani, N., Waterworth, D., Batty, S. et al. (1997) The genetic basis of polycystic ovary syndrome. Hum. Reprod., 12, 2641-2648.
19. Garcia, J., Jones, G.S. and Wentz, A.C. (1977) The use of clomiphene citrate. Fertil. Steril., 28, 707-717.
20. Gjönnaess, H. (1984) Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil. Steril., 41, 20-25.
21. Homburg, R. (1996) Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy. Hum. Reprod., 11, 29-39.
22. Homburg, R., Eshel, A., Kilborn, J. et al. (1990) Combined luteinizing hormone-releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovary syndrome. Hum. Reprod., 5, 32-35.
23. Insler, V. and Lunenfeld, B. (1991) Pathophysiology of polycystic ovarian disease: new insights. Hum. Reprod., 6, 1025-1029.
24. Judd, H.L., Rigg, L.A., Anderson, D.C. and Yen, S.S.C. (1976) The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 43, 347-355.
25. Katz, M., Carr, P.J., Cohen, B.M. and Millar, R.P. (1978) Hormonal effects of wedge resection of polycystic ovaries. Obstet. Gynecol., 51, 437-444.
26. Khan, C.R., Flier, J.S., Bar, R.S. et al. (1976) The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man. N. Eng. J. Med., 294, 739-745.
27. Kiddy, D.S., Hamilton-Fairley, D., Bush, A. et al. (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol., 36, 105-111.
28. Kol, S., Ben-Shlomo, I., Ruutiainen, K. et al. (1997) Interleukin-1-dependent regulation of glucose transporters in the immature rat ovary: a specific receptor-mediated effect. J. Clin. Invest., 99, 2274-2283.
29. Lanzone, A., Fulghesu, A.M., Andreani, C.L. et al. (1990) Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist. Hum. Reprod., 5, 143-149.
30. Navot, D., Bergh, P.A. and Laufer, N. (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 58, 249-261.
31. Nestler, J.E. and Jakubowicz, D.J. (1996) Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N. Eng. J. Med., 335, 617-623.
32. Polson, D.W., Adams, J., Wadsworth, J. and Franks, S. (1988) Polycystic ovaries - a common finding in normal women. Lancet, 1, 870-872.
33. Rosenfield, R.L., Barnes, R.B., Cara, J.F. and Lucky, A.W. (1990) Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil. Steril., 53, 785-791.
34. Scaramuzzi, R.J., Davidson, W.G. and Van-Look, P.F.A. (1977) Increasing ovulation rate in sheep by active immunisation against an ovarian steroid androstenedione. Nature, 269, 817-818.
35. Stein, I.F. and Leventhal, M.L. (1935) Amenorrhea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol., 29, 181-191.
36. Van den Berg, G. and Yen, S.S.C. (1973) Effect of anti-estrogenic action of clomiphene during the menstrual cycle: evidence for a change in the feedback sensitivity. J. Clin. Endocrinol. Metab., 37, 356-365.
37. Wang, C.F. and Gemzell, C. (1980) The use of human gonadotropin for the induction of ovulation in women with polycystic ovarian disease. Fertil. Steril., 33, 479-486.
38. Willis, D. and Franks, S. (1995) Insulin action in human granulosa cells from normal and polycystic ovaries is mediated the insulin receptor and not the type-I insulin-like growth factor receptor. J. Clin. Endocrinol. Metab., 80, 3788-3790.
39. Willis, D., Mason, H., Gilling-Smith, C. and Franks, S. (1996) Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J. Clin. Endocrinol. Metab., 81, 302-309.